Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice

Seyedhossein Aharinejad, Dietmar Abraham, Patrick Paulus, Hojatollah Abri, Michael Hofmann, Karl Grossschmidt, Romana Schiller, E. Richard Stanley, Reinhold Hofbauer

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

Matrix metalloproteinases (MMPs) foster cellular invasion by disrupting extracellular matrix barriers and thereby facilitate tumor development. MMPs are synthesized by both cancer cells and adjacent stromal cells, primarily macrophages. The production of macrophages is regulated by colony-stimulating factor-1 (CSF-1). Tissue CSF-1 expression increased significantly in embryonic and colon cancer xenografts. We, therefore, hypothesized that blocking CSF-1 may suppress tumor growth by decelerating macrophage-mediated extracellular matrix breakdown. Cells expressing CSF-1 and mice xenografted with CSF-1 receptor (cfms)- and CSF-1-negative malignant human embryonic or colon cancer cells were treated with mouse CSF-1 antisense oligonucleotides. Two weeks of CSF-1 antisense treatment selectively down-regulated CSF-1 mRNA and protein tissue expression in tumor lysates. CSF-1 blockade suppressed the growth of embryonic tumors to dormant levels and the growth of the colon carcinoma by 50%. In addition, tumor vascularity and the expression of MMP-2 and angiogenic factors were reduced. Six-month survival was observed in colon carcinoma mice only after CSF-1 blockade, whereas controls were all dead at day 65. These results suggest that human embryonic and colon cancer cells up-regulate host CSF-1 and MMP-2 expression. Because the cancer cells used were CSF-1 negative, CSF-1 antisense targeted tumor stromal cell CSF-1 production. CSF-1 blockade could be a novel strategy in treatment of solid tumors.

Original languageEnglish (US)
Pages (from-to)5317-5324
Number of pages8
JournalCancer Research
Volume62
Issue number18
StatePublished - Sep 15 2002
Externally publishedYes

Fingerprint

Macrophage Colony-Stimulating Factor
Heterografts
Growth
Neoplasms
Colonic Neoplasms
Matrix Metalloproteinase 2
Macrophages
Stromal Cells
Matrix Metalloproteinases
Extracellular Matrix
Colon
Colony-Stimulating Factor Receptors
Carcinoma
Antisense Oligonucleotides
Angiogenesis Inducing Agents

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Aharinejad, S., Abraham, D., Paulus, P., Abri, H., Hofmann, M., Grossschmidt, K., ... Hofbauer, R. (2002). Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice. Cancer Research, 62(18), 5317-5324.

Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice. / Aharinejad, Seyedhossein; Abraham, Dietmar; Paulus, Patrick; Abri, Hojatollah; Hofmann, Michael; Grossschmidt, Karl; Schiller, Romana; Stanley, E. Richard; Hofbauer, Reinhold.

In: Cancer Research, Vol. 62, No. 18, 15.09.2002, p. 5317-5324.

Research output: Contribution to journalArticle

Aharinejad, S, Abraham, D, Paulus, P, Abri, H, Hofmann, M, Grossschmidt, K, Schiller, R, Stanley, ER & Hofbauer, R 2002, 'Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice', Cancer Research, vol. 62, no. 18, pp. 5317-5324.
Aharinejad S, Abraham D, Paulus P, Abri H, Hofmann M, Grossschmidt K et al. Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice. Cancer Research. 2002 Sep 15;62(18):5317-5324.
Aharinejad, Seyedhossein ; Abraham, Dietmar ; Paulus, Patrick ; Abri, Hojatollah ; Hofmann, Michael ; Grossschmidt, Karl ; Schiller, Romana ; Stanley, E. Richard ; Hofbauer, Reinhold. / Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice. In: Cancer Research. 2002 ; Vol. 62, No. 18. pp. 5317-5324.
@article{584797cc5d31479b88f842aaba77d6cb,
title = "Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice",
abstract = "Matrix metalloproteinases (MMPs) foster cellular invasion by disrupting extracellular matrix barriers and thereby facilitate tumor development. MMPs are synthesized by both cancer cells and adjacent stromal cells, primarily macrophages. The production of macrophages is regulated by colony-stimulating factor-1 (CSF-1). Tissue CSF-1 expression increased significantly in embryonic and colon cancer xenografts. We, therefore, hypothesized that blocking CSF-1 may suppress tumor growth by decelerating macrophage-mediated extracellular matrix breakdown. Cells expressing CSF-1 and mice xenografted with CSF-1 receptor (cfms)- and CSF-1-negative malignant human embryonic or colon cancer cells were treated with mouse CSF-1 antisense oligonucleotides. Two weeks of CSF-1 antisense treatment selectively down-regulated CSF-1 mRNA and protein tissue expression in tumor lysates. CSF-1 blockade suppressed the growth of embryonic tumors to dormant levels and the growth of the colon carcinoma by 50{\%}. In addition, tumor vascularity and the expression of MMP-2 and angiogenic factors were reduced. Six-month survival was observed in colon carcinoma mice only after CSF-1 blockade, whereas controls were all dead at day 65. These results suggest that human embryonic and colon cancer cells up-regulate host CSF-1 and MMP-2 expression. Because the cancer cells used were CSF-1 negative, CSF-1 antisense targeted tumor stromal cell CSF-1 production. CSF-1 blockade could be a novel strategy in treatment of solid tumors.",
author = "Seyedhossein Aharinejad and Dietmar Abraham and Patrick Paulus and Hojatollah Abri and Michael Hofmann and Karl Grossschmidt and Romana Schiller and Stanley, {E. Richard} and Reinhold Hofbauer",
year = "2002",
month = "9",
day = "15",
language = "English (US)",
volume = "62",
pages = "5317--5324",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "18",

}

TY - JOUR

T1 - Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice

AU - Aharinejad, Seyedhossein

AU - Abraham, Dietmar

AU - Paulus, Patrick

AU - Abri, Hojatollah

AU - Hofmann, Michael

AU - Grossschmidt, Karl

AU - Schiller, Romana

AU - Stanley, E. Richard

AU - Hofbauer, Reinhold

PY - 2002/9/15

Y1 - 2002/9/15

N2 - Matrix metalloproteinases (MMPs) foster cellular invasion by disrupting extracellular matrix barriers and thereby facilitate tumor development. MMPs are synthesized by both cancer cells and adjacent stromal cells, primarily macrophages. The production of macrophages is regulated by colony-stimulating factor-1 (CSF-1). Tissue CSF-1 expression increased significantly in embryonic and colon cancer xenografts. We, therefore, hypothesized that blocking CSF-1 may suppress tumor growth by decelerating macrophage-mediated extracellular matrix breakdown. Cells expressing CSF-1 and mice xenografted with CSF-1 receptor (cfms)- and CSF-1-negative malignant human embryonic or colon cancer cells were treated with mouse CSF-1 antisense oligonucleotides. Two weeks of CSF-1 antisense treatment selectively down-regulated CSF-1 mRNA and protein tissue expression in tumor lysates. CSF-1 blockade suppressed the growth of embryonic tumors to dormant levels and the growth of the colon carcinoma by 50%. In addition, tumor vascularity and the expression of MMP-2 and angiogenic factors were reduced. Six-month survival was observed in colon carcinoma mice only after CSF-1 blockade, whereas controls were all dead at day 65. These results suggest that human embryonic and colon cancer cells up-regulate host CSF-1 and MMP-2 expression. Because the cancer cells used were CSF-1 negative, CSF-1 antisense targeted tumor stromal cell CSF-1 production. CSF-1 blockade could be a novel strategy in treatment of solid tumors.

AB - Matrix metalloproteinases (MMPs) foster cellular invasion by disrupting extracellular matrix barriers and thereby facilitate tumor development. MMPs are synthesized by both cancer cells and adjacent stromal cells, primarily macrophages. The production of macrophages is regulated by colony-stimulating factor-1 (CSF-1). Tissue CSF-1 expression increased significantly in embryonic and colon cancer xenografts. We, therefore, hypothesized that blocking CSF-1 may suppress tumor growth by decelerating macrophage-mediated extracellular matrix breakdown. Cells expressing CSF-1 and mice xenografted with CSF-1 receptor (cfms)- and CSF-1-negative malignant human embryonic or colon cancer cells were treated with mouse CSF-1 antisense oligonucleotides. Two weeks of CSF-1 antisense treatment selectively down-regulated CSF-1 mRNA and protein tissue expression in tumor lysates. CSF-1 blockade suppressed the growth of embryonic tumors to dormant levels and the growth of the colon carcinoma by 50%. In addition, tumor vascularity and the expression of MMP-2 and angiogenic factors were reduced. Six-month survival was observed in colon carcinoma mice only after CSF-1 blockade, whereas controls were all dead at day 65. These results suggest that human embryonic and colon cancer cells up-regulate host CSF-1 and MMP-2 expression. Because the cancer cells used were CSF-1 negative, CSF-1 antisense targeted tumor stromal cell CSF-1 production. CSF-1 blockade could be a novel strategy in treatment of solid tumors.

UR - http://www.scopus.com/inward/record.url?scp=0037105725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037105725&partnerID=8YFLogxK

M3 - Article

C2 - 12235002

AN - SCOPUS:0037105725

VL - 62

SP - 5317

EP - 5324

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 18

ER -